Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
At Geneva, providers assess weight history, metabolic markers, insulin response, and prior treatment experience to determine which option is most likely to deliver safe, sustainable results for each patient
Clinical Evidence and Ongoing Trials A 2023 Phase 2 trial in the New England Journal of Medicine reported approximately 24% mean body weight reduction at 48 weeks with the 12 mg dose
After successfully launching the Omnipod 5 in the UK and Germany, Insulet is gearing up to expand its presence in additional European markets, with the goal of making the Omnipod 5 accessible to "the majority" of its European customers by the end of 2024
With that said, its a good idea to check with a licensed healthcare provider before adding any medication, especially if you have other health conditions or are taking additional prescriptions
